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IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus
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Abstract
Type III secretion (T3S) systems are used by numerous Gram-negative pathogenic bacteria to inject virulence proteins into animal and plant
host cells. The core of the T3S apparatus, known as the needle complex, is composed of a basal body transversing both bacterial membranes and a
needle protruding above the bacterial surface. In Shigella flexneri, IpaD is required to inhibit the activity of the T3S apparatus prior to contact of
bacteria with host and has been proposed to assist translocation of bacterial proteins into host cells. We investigated the localization of IpaD by
electron microscopy analysis of cross-linked bacteria and mildly purified needle complexes. This analysis revealed the presence of a distinct
density at the needle tip. A combination of single particle analysis, immuno-labeling and biochemical analysis, demonstrated that IpaD forms part
of the structure at the needle tip. Anti-IpaD antibodies were shown to block entry of bacteria into epithelial cells.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Many Gram-negative pathogenic bacteria use a type three
secretion (T3S) system to interact with cells of their host. Each
T3S system consists of a secretion apparatus (T3SA) that spans
the bacterial envelope and extends on the bacterial surface,
translocators that transit through the T3SA and insert into the
membrane of the host cell where they form a pore, effectors that
transit through the T3SA and the translocator pore to reach the
cell cytoplasm, specific chaperones that associate with translo-
cators and effectors in the bacterial cytoplasm and transcrip-
tional regulators. Approximately 15 proteins are required for
assembly of the T3SA.
Bacteria belonging to the Shigella genus are the causative
agents of bacillary dysentery in humans [1]. Genes required for
entry of bacteria into epithelial cells and inducing apoptosis in
macrophages are clustered in a 30-kb region, designated the
entry region, of a 220-kb virulence plasmid. The entry region
contains 20 mxi and spa genes encoding components of the
T3SA, the ipaA, B, C and D, ipgB1, ipgD and icsB genes
encoding proteins that transit through the T3SA, the ipgA,
ipgC, ipgE and spa15 genes encoding chaperones, and the virB
and mxiE genes encoding transcriptional regulators [2].
The T3SA, which is weakly active in bacteria growing in
broth, is activated upon contact of bacteria with epithelial cells
[3]. Inactivation of ipaB, ipaC or ipaD, as well as most mxi and
spa genes, abolishes the ability of bacteria to enter epithelial
cells, induce apoptosis in macrophages and express contact
hemolytic activity. IpaB and IpaC contain hydrophobic
segments and remained associated with the membrane of
lysed erythrocytes, suggesting that these two proteins are
components of the S. flexneri translocator. In addition, effector
functions have been proposed for IpaB and IpaC [4–8].
Inactivation of ipaB and ipaD, but not ipaC, leads to a
deregulated, i.e. constitutively active, T3SA, suggesting that
IpaB and IpaD play a role in maintaining the T3SA inactive in
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associated with the bacterial envelope [9,11]. Picking and
collaborators [12] reported that the role of IpaD in the control of
the T3SA activity can be separated from its role in entry of
bacteria into epithelial cells.
To get further insights on the structure of the needle complex,
we performed an immuno-electron microscopic analysis on
bacteria treated with the cross-linking agent BS
3, both on entire
bacteria and on the mildly purified needle complex (NC). We
presentevidencethat IpaDisacomponentoftheNClocalizedat
the tip of the needle and that antibodies raised against IpaD have
an inhibitory effect on entry of S. flexneri into epithelial cells.
2. Materials and methods
2.1. Bacterial strains and growth media
Strains used in this study are the wild-type S. flexneri 5 strain M90T-Sm
[13], its ipaD derivative SF622 [14]. Bacteria were grown in tryptic casein soy
broth (TSB) (Sigma) at 37 °C.
2.2. Purification of NC
NCs were purified as described [15]. Bacteria in the exponential phase of
growth in 1 l of TSB at 37 °C were collected by centrifugation, resuspended in
25 ml of phosphate-buffered saline and incubated in the presence of 1 mM Bis
(Sulfosuccinimidyl)suberate (BS
3) for 30 min at 37 °C. The mixture was
supplemented with 100 mM Tris–HCl and incubated for 15 min at 37 °C. BS
3-
treated cultures were harvested and resuspended in an ice-cold lysis buffer
(0.5 M sucrose, 20 mM Tris–HCl [pH 7.5], 2 mM EDTA, 0.5 mg/ml lysozyme)
supplemented with 1 mM phenylmethylsulfonyl fluoride and incubated for
45 min at 4 °C and for 15 min at 37 °C. Resulting spheroplasts were incubated
with0.01%Triton X-100for 30min andtreated with4mM MgCl2 and80 μg/ml
DNAse (Sigma) for 20 min at 30 °C. Debris were removed by centrifugation
(20,000×g for 20 min at 4 °C) and the membrane fraction was pelleted by
centrifugation (110,000×g for 30 min at 4 °C) and resuspended in TET buffer
(20 mM Tris–HCl pH 7.5, 1 mM EDTA, 0.01% Triton X-100). Immunoblotting
analysis was performed with antibodies raised against MxiJ, MxiN and IpaD as
described [16].
2.3. Electron microscopy and image analysis
Whole cells and samples of purified NCs were negatively stained with 2%
uranyl acetate on glow discharged carbon-coated copper grids. Electron
microscopy was performed on a Philips CM120FEG equipped with a field
emission gun operated at 120 kV. Images were recorded with a 4000 SP 4 K
slow-scan CCD camera at 80,000× magnification at a pixel size (after binning
the images) of 3.75 Å at the specimen level, with “GRACE” software for semi-
automated specimen selection and data acquisition [17]. Single particle analysis
including multi-reference and non-reference procedures, multivariate statistical
analysis and classification was performed as described [15]. For immuno-
labeling, purified NCs were incubated with affinity purified IpaD polyclonal
antibodies (pAbs) at a final concentration of 0.132 ng/μl) for 1 h at 20 °C.
Samples were stained with 2% uranyl acetate and observed as above.
2.4. Invasion assay
Two ml of cultures of wild-type or mxiD strains in the exponential phase of
growth (OD600 nm of 0.4) were washed twice with 2 ml EBSS before incubation.
They were incubated in the presence of serum from rabbits immunized against
IpaD (anti-IpaD dilution 1/2000:0.132 ng/μl to 1/50: 15.6 ng/μl) or anti-IpaB (1/
50) (same concentration) antibodies for 1 h at 37 °C and bacteria were
centrifuged on plates containing 2×10
5 HeLa cells for 10 min at 2000×g. After
1 h incubation at 37 °C, cells were washed three times with 2 ml EBSS and
incubated during 1 h with 2 ml MEM milieu containing 50 μg/ml gentamycin.
After three washes with 2 ml EBSS, plates were incubated with a solution of
deoxycholate 0.5% for 15 min at 20 °C and cell lysates were diluted and plated
on agar plates for colony counting.
3. Results
3.1. A distinctive structure at the tip of the T3SA needle
Protein purification procedures tend to select for most stable
complexes that might not contain weakly associated subunits.
We recently showed that a Triton-X100 detergent concentration
as low as 0.01% was sufficient to induce the release of NCs
from the membrane [15]. To detect potentially labile subunits
attached to the needle, we performed a cross-linking step with
BS
3 on bacteria prior to any purification. Electron microscopy
analysis indicated that, following BS
3 treatment, most bacteria
exhibited needle appendages with an additional density at the
extremity of the tip (Fig. 1).
NCs were purified from BS
3-treated bacteria after detergent
solubilization of membranes as described [18]. Preparations
contained a sufficient number of NCs with the additional
densities at the needle tip to perform a structural analysis. To
Fig. 1. Electron micrographs of negatively stained bacteria treated with BS
3. Arrows indicate distinct densities at the tip of needles protruding from the bacterial
surface. The bar represents 100 nm.
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electron microscopy images were analyzed by single particle
analysis. We selected several hundred images of NCs with a
relatively straight and short needle appendage and a length close
to 45 nm. The averaged NCs clearly showed the presence of a
density around the needle tip, as well as the upper part of the
basal body (Fig. 2A and B; see also Fig. 4E for a total view of a
NC). However, NCs appeared a bit blurred after averaging as a
result of variations in the needle length. Sharper features at the
tip of the needle portion were obtained when projections were
aligned and classified after masking the basal part (Fig. 2C).
Striking features of the average map of cross-linked particles are
the presence of densities at either side of the needle tip. In
contrast, average maps of particles prepared from the wild-type
strain without cross-linking showed needles lacking most of
these densities (Fig. 2D–F). Faint densities are visible in these
samples at the same position where the strong densities were
present in cross-linked preparations (arrows, Fig. 2E and F).
These results suggest that, in the absence of cross-linking, most
purified NCs lost the additional molecule(s) forming the density
observed after cross-linking. To identify molecule(s) forming
the density at the tip of the T3SA, we performed similar
experiments with an ipaD mutant lacking the IpaD expression.
IpaD is required, together with IpaB, to maintain the T3SA
inactive in the absence of inducers and a small proportion of
IpaD is membrane associated [9]. NCs purified from the BS
3-
treated ipaD mutant did not exhibit densities at either side of the
needle tip (Fig. 2G–I), suggesting that IpaD is part of or
required for assembly of this structural element.
3.2. IpaD is present at the tip of the T3SA needle
To test whether IpaD constitutes the observed density, NCs
purified from BS
3-treated wild-type bacteria were analyzed by
SDS-PAGE and immunoblotting (Fig. 3). IpaD was enriched in
Fig.2. Projectionmaps (class-sums) of the needle partof NCs obtainedby single
particle analysis. (A–B) maps of NCs isolated from wild-type, treated with BS
3
(A–C); from wild-type without BS
3 treatment (D–F) and from an ipaD mutant
strain with BS
3 treatment (G–I). The arrows point to remnant densities attached
to needle parts prepared without BS
3-treatment. The bar represents 10 nm.
Fig. 3. (A) Immunobloting analysis of purified NCs. Whole cell extracts (WCE)
and cross linked (+CR) and non-cross linked (−CR) NCs purified from wild-
type and IpaD deficient strains were analyzed by SDS-PAGE and immunoblot-
ting using antibodies specific to MxiJ, MxiN, and IpaD. IpaD was only enriched
to WCE level in NCs prepared from cross-linked wild-type bacteria. MxiJ is a
positive control to demonstrate intact T3SA. MxiN, a cytoplasmic component of
T3S, is a positive control to demonstrate contamination by non-bound
cytoplasmic proteins.
Fig. 4. IpaD localization by immuno-electron microscopy. NCs purified from
BS
3-treated wild-type bacteria were incubated with anti-IpaD antibodies and
negatively stained (A–D). The average image of 250 NCs purified from bacteria
nottreatedwithBS
3isshowninpanelEforcomparison.Thebarrepresents10nm.
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pared to NCs prepared from non-cross-linked bacteria (Fig. 3,
right panel, right lane), though small amounts also co-purify in
non-cross linked preparation and thus corroborate the faint
densities at the needle tip for averages of non-cross linked NCs.
MxiJ that is a major NC component is present in similar
amounts in all preparations (Fig. 3). Control experiments using
antibodies recognizing cytoplasmic components of the T3S
system, such as MxiN, did not reveal any contamination of NCs
by intracellular components (Fig. 3), indicating that the
presence of IpaD in the preparations was not due to a
contamination by cytoplasmic proteins.
To confirm that densities detected at the tip of NCs contained
IpaD,weperformedimmuno-stainingusing ananti-IpaDserum.
Antibodies specifically bound to the tip of the needle in NCs
prepared from BS
3 treated wild-type bacteria (Fig. 4A–D).
Some needles were also observed to be associated by their tip,
presumably as a result of the interaction to bivalent antibodies
with two needles (lower left frame, Fig. 4D). In control
experiments, no antibodies were found to bind the needle of
NCs isolated from the ipaD mutant (data not shown).
3.3. Anti-IpaD antibodies blocks entry of bacteria into
epithelial cells
Since IpaD is required for entry of bacteria into epithelial
cells [14] and since, as shown here, it is localized at the tip of the
T3SA, we investigated whether anti-IpaD antibodies might
interfere with entry of bacteria into HeLa cells. Bacteria
incubated with different concentrations of the anti-IpaD serum,
or an anti-IpaB serum as a control, were used to infect HeLa
cells. Exposure of bacteria to the anti-IpaD serum, but not to the
anti-IpaB serum, inhibited bacterial entry in a dose-dependent
manner (Fig. 5). Treatment with the anti-IpaD antibodies also
inhibited entry of a S. flexneri 2a strain (data not shown).
4. Discussion
The S. flexneri T3SA is activated upon contact of bacteria
with epithelial cells and is deregulated by inactivation of ipaB
or ipaD. It was proposed that these proteins are required to
form a complex plugging the T3SA. Here, we presented
evidence that IpaD is present at the tip of the needle.
Transmission electron micrograph of surface exposed needles
from cross-linked bacteria showed a distinctive structure
present at the tip of the needle and immunoblot analysis of
mildly purified NCs indicated that IpaD is copurified with the
cross-linked NCs.
Calculated averages of NCs isolated from cross-linked wild-
type bacteria showed distinct densities at either sides of the
needle tip. This feature was not observed in NCs isolated from
both the wild-type strain that had not been treated with the
cross-linker and from the ipaD mutant treated with the cross-
linker. Results of immunoelectron microscopy indicate that the
observed density at the tip of the needle contains IpaD
molecules. The exact configuration of the additional density,
however, cannot be retrieved from 2D projection maps. The
two additional masses have dimensions of about 7×7 nm.
Since the size of IpaD is 37-kDa, several copies of IpaD are
probably present in these structures. Indeed, IpaD has been
proposed to form oligomers [19] IpaD presents some
functional analogies with LcrV of Yersinia enterocolitica,
inasmuch as the two proteins have similar sizes and are both
required for insertion of the proposed translocators, IpaB and
IpaC in S. flexneri and YopB and UopD in Y. enterocolitica,i n
the membrane of host cells [9,20,21]. Recent data indicated
that LcrV is localized at the tip of the T3SA needle [20]. The
structure in Yersinia appears to be slightly different to that in
Shigella with smaller protruding densities at the side and
with a different tip.
The identification of a structural element containing IpaD at
the tip of the T3SA needle provides further insights on the
composition and structure of the S. flexneri T3SA. Very
recently it was also demonstrated with both biochemical and
immunoelectron microscopy methods that IpaD localizes to the
T3SA needle tip, where it functions to control the secretion and
proper insertion of translocators into host cell membranes [22].
Our single particle analysis, however, directly demonstrates the
position of IpaD at the tip of the needle and adds credence to the
hypothesis that IpaD acts as a plug to the T3SA prior to contact
of bacteria with cells. As proposed for LcrV in Yersinia, IpaD
might also facilitate insertion of components of the translocators
within the cell membrane. The inhibition of entry of bacteria
into HeLa cells by treatment with anti-IpaD antibodies indicates
that binding of antibodies to IpaD interferes with the function of
the protein. LcrV has also been shown to be a protective antigen
for plague disease in animal studies [23,24]. Accordingly, IpaD
might represent an interesting target for the preparation of
vaccines that would be effective against several serotypes of
Shigella.
Fig. 5. Invasion assay of epithelial cells by wild-type S. flexneri. Bacteria were
incubated with serial dilutions of the anti-IpaD or anti-IpaB polyclonal
antibodies and intracellular, gentamycin-resistant bacteria were counted by
plating cell lysates. The efficiency of entry in each condition is expressed with
respect to that of the wild-type strain treated with PBS. The values are the means
of at least three independent experiments, and the error bars indicate standard
deviations.
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